PharmaTher Launches 3D Printed Medicine Network in the U.S.
Written with artificial intelligence.
PharmaTher is establishing the M3DICINES National Network Program to create a network of U.S. locations capable of 3D printing medicines on demand. This initiative aims to enhance personalized medicine by enabling localized production, particularly for drugs that are difficult to manufacture in large quantities.
Overview of the M3DICINES National Network Program
PharmaTher, a Canadian pharmaceutical company, is launching the M3DICINES National Network Program to develop a distributed network for 3D printing medications closer to patients. This innovative approach will initially engage U.S. compounding pharmacies and may expand to include hospitals and research institutions.
Craft Health Partnership
The network will utilize Craft Health's CraftMake pharmaceutical 3D printer, which PharmaTher began distributing on October 1. With plans to install up to 50 CraftMake printers within the next year, the first sites will include PD Labs, a compounding pharmacy in the U.S.
Benefits of the Network Model
The proposed network allows for the validation of drug formulations at a central location, followed by local production at qualified sites. This system is designed to address the challenges of manufacturing small batches for personalized doses, rare diseases, and clinical trials. Each CraftMake printer can produce various doses and handle temperature-sensitive drugs, ensuring a flexible approach to medication production.
Regulatory Landscape
PharmaTher's initiative aligns with potential regulatory changes from the U.S. Food and Drug Administration (FDA) regarding distributed drug manufacturing. While the network currently targets compounding pharmacies, it highlights a trend toward decentralizing pharmaceutical production, particularly in emergencies where local production can mitigate supply issues.
Future Plans
PharmaTher aims to test its emergency network and pursue contracts with U.S. and Canadian government agencies over the coming year. However, the rollout of the network is still in the planning phase, with site qualifications and installations underway.